Evidence map›Paper›PMID 28727226›Full record

ArticleThe breast journal2018

Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.

Steven Lehrer, Sheryl Green, Kenneth E Rosenzweig

Abstract readLetter
In one paragraph

Article in The breast journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Steven LehrerDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sheryl GreenDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kenneth E RosenzweigDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Funding

POLYMORPHIC ESTROGEN RECEPTOR M-RNA IN BREAST CANCERR01CA049506 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI LEHRER, STEVEN P · 1989 to 1991
–
NCI NIH HHS R01 CA049506
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Apoptosis Regulatory ProteinsAromatase InhibitorsBrain NeoplasmsBreast NeoplasmsFemaleGlioblastomaHumansNeoplasms, Second PrimaryPTEN PhosphohydrolaseRisk FactorsRNA-Binding ProteinsApoptosis Regulatory ProteinsAromatase InhibitorsPDCD4 protein, humanPTEN PhosphohydrolasePTEN protein, humanRNA-Binding Proteins

Identifiers

PMID28727226
PMCPMC6530546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.